BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynolds S. Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach. J Multidiscip Healthc 2015;8:345-58. [PMID: 26251611 DOI: 10.2147/JMDH.S54802] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Dibattista M, Lobasso S, Stramaglia S, Corcelli A. Assessing olfactory functions in patients with Barth syndrome. PLoS One 2017;12:e0187619. [PMID: 29099864 DOI: 10.1371/journal.pone.0187619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Garlid AO, Schaffer CT, Kim J, Bhatt H, Guevara-Gonzalez V, Ping P. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome. Gene 2020;726:144148. [PMID: 31647997 DOI: 10.1016/j.gene.2019.144148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brambilla A, Olivotto I, Favilli S, Spaziani G, Passantino S, Procopio E, Morrone A, Donati MA. Impact of cardiovascular involvement on the clinical course of paediatric mitochondrial disorders. Orphanet J Rare Dis 2020;15:196. [PMID: 32736646 DOI: 10.1186/s13023-020-01466-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zegallai HM, Hatch GM. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets. Mol Cell Biochem 2021;476:1605-29. [PMID: 33415565 DOI: 10.1007/s11010-020-04021-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]